Does a GnRH Agonist Given at Embryo Transfer Improve Clinical Pregnancy and Live Birth Rates of Women Undergoing In-Vitro Fertilization?
Status: Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 18 Apr 2019
Price : $35 *
At a glance
- Drugs Leuprorelin (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms GRAET
- 12 Apr 2019 Status changed from not yet recruiting to withdrawn prior to enrolmentas the investigators were not able to grant funding for this study.
- 25 Oct 2018 Planned initiation date changed from 1 Oct 2018 to 1 Nov 2018.
- 15 Aug 2018 Planned initiation date changed from 1 Jul 2018 to 1 Oct 2018.